These include: Nausea (very common, may affect more than 1 in 10 people) Diarrhoea (very common) Vomiting (common, may affect up to 1 in 10 people) Constipation and abdominal pain (common) Decreased appetite (very common) These gastrointestinal symptoms typically diminish over time as the body adjusts to the medication
(More information) There is some low-quality evidence to suggest that supplemental L-carnitine or ALCAR may be beneficial as adjuncts to standard medical therapy of depression, Alzheimer's disease, and hepatic encephalopathy
What we really dont control and dont attempt to but as a reality is that downstream customers from Lilly wholesalers and retailers are making their own decisions about which of the 12 different dosage forms they want to stock in at what level, Ricks said
Current evidence shows: Research is ongoing to determine how newer oral formulations will compare long-term
This increases accessibility to a wider range of patients at a fraction of the cost
You may also learn more about our law firm by visiting www.littlehealthlaw.com